SEC Form 4 · accession 0001062993-15-003150
BIOSPECIFICS TECHNOLOGIES CORP · BSTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Gitman
Director
Period of report
May 29, 2015
Accepted (ET)
Jun 1, 2015 · 11:56 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875622
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1 | May 29, 2015 | S | 11,000 | $46.75 | D | 55,825 | D | |
| Common Stock, $0.001 par valueF1 | May 29, 2015 | S | 4,000 | $46.79 | D | 51,825 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transactions reported in this Form 4 were effected outside of the Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2014 in an open trading window.